S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Investors Face September Deadline in Park Ha Securities Litigation

Investors who purchased Park Ha Biological Technology Co., Ltd. securities between December 27, 2024, and July 8, 2025, face a September 28, 2026, deadline to seek appointment as lead plaintiff. The Rosen Law Firm is spearheading the class action, targeting alleged misleading disclosures regarding the company's stock trading activity.

Investors Face September Deadline in Park Ha Securities Litigation
Photo: Bio & News

The lawsuit alleges that Park Ha misled shareholders by failing to disclose a fraudulent stock promotion scheme that utilized social media misinformation and impersonated financial professionals to drive share prices. According to the complaint, the company’s IPO was structured with an intentionally low public float to facilitate this manipulation, while public risk disclosures omitted the impact of artificial trading activity. Investors who suffered losses exceeding $100,000 are encouraged to contact the firm to discuss their eligibility to lead the litigation.

Legal counsel Phillip Kim noted that affected investors may be entitled to compensation through a contingency fee arrangement, meaning no out-of-pocket costs are required. While a class action has been filed, no class has yet been certified. Investors retain the right to select their own counsel or remain absent members of the class without taking immediate action. Those interested in participating can register via the Rosen Law Firm website or reach out directly to the New York-based firm for further details on the proceedings.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!